1. Nippon Shinyaku Co., Ltd. - Product Pipeline Review - 2015 Published on : October - 2015

2. About Nippon Shinyaku Co., Ltd. - Product Pipeline Review - 2015 Research Beam added report on “Nippon Shinyaku Co., Ltd. Product Pipeline Review - 2015”. Summary Global Markets Directs, Nippon Shinyaku Co., Ltd. Product Pipeline Review - 2015, provides an overview of the Nippon Shinyaku Co., Ltd. s Nippon Shinyaku Co., Ltd. research and development focus. This report provides comp rehensive information on the current therapeutic developmental pipeline of Nippon Shinyaku Co., Ltd. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Full Details On : http://www.researchbeam.com/nippon-shinyaku-co-ltd-product-pipeline- review-2015-markethttp://www.researchbeam.com/nippon-shinyaku-co-ltd-product-pipeline- review-2015-market Report Overview.

3. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Report Overview.

4. Scope The report provides brief overview of Nippon Shinyaku Co., Ltd. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Nippon Shinyaku Co., Ltd. s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Nippon Shinyaku Co., Ltd. s pipeline products Reasons to buy Evaluate Nippon Shinyaku Co., Ltd. s strategic position with total access to detailed information on its product pipeline. Report Overview

5. Assess the growth potential of Nippon Shinyaku Co., Ltd. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Nippon Shinyaku Co., Ltd. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Nippon Shinyaku Co., Ltd. and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nippon Shinyaku Co., Ltd. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Explore the dormant and discontinued projects of Nippon Shinyaku Co., Ltd. and identify potential opportunities in those areas Report Overview

6. Table of Contents 2 List of Tables 4 List of Figures 4 Nippon Shinyaku Co., Ltd. Snapshot 5 Nippon Shinyaku Co., Ltd. Overview 5 Key Information 5 Key Facts 5 Nippon Shinyaku Co., Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Nippon Shinyaku Co., Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Table Of Contents

7. Nippon Shinyaku Co., Ltd. - Pipeline Products Glance 12 Nippon Shinyaku Co., Ltd. - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Phase III Products/Combination Treatment Modalities 13 Nippon Shinyaku Co., Ltd. - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Nippon Shinyaku Co., Ltd. - Drug Profiles 16 selexipag 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 prulifloxacin 18 Product Description 18

8. Mechanism of Action 18 R&D Progress 18 afacifenacin 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 NS-141 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 NS-018 22 Enquiry about this report @ http://www.researchbeam.com/nippon-shinyaku-co-ltd-product- pipeline-review-2015-market/enquire-about-reporthttp://www.researchbeam.com/nippon-shinyaku-co-ltd-product- pipeline-review-2015-market/enquire-about-report Table Of Contents

9. FOR MORE DETAILS Visit us at : http://www.researchbeam.com/nippon-shinyaku-co-ltd- product-pipeline-review-2015-market Stay With Us: 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States TELEPHONE: +1 (800) 910-6452 E-MAIL: sales@researchbeam.com